Hints and tips:
Related Special Reports
...The move marks an increase from $3bn in deals in 2023 and a step change in ambitions for Novo Holding’s investments portfolio....
...In the latter half of the decade its market value languished at around the $100bn mark. These days, Lilly is the world’s most valuable drugmaker, after overtaking Johnson & Johnson last summer....
...The results of the closely watched trial mark the second significant breakthrough in a year for a drug aiming to treat a disease with about 50mn sufferers worldwide....
...Its non-tech winners included Apollo Global, Eli Lilly, Airbus and online gambling company Flutter....
...Novo Nordisk, Eli Lilly and others are racing to develop the next generation of weight loss drugs....
...Celebrations will ring out across Asia and beyond this Saturday with the beginning of the next lunar year — the year of the dragon for most countries that mark the occasion....
...Some good news Some welcome news to mark International Women’s Day....
...The results mark the second significant breakthrough in a year for a class of drugs targeting a disease that is the most common cause of dementia and for which there is no cure....
...Millennium Management is in advanced talks to put billions of dollars to work with smaller rival Schonfeld Strategic Advisors, according to people familiar with the situation, in a partnership deal that would mark...
...Rival drugmaker Eli Lilly, which is developing a similar Alzheimer’s drug, has also criticised CMS for linking reimbursement to a registry....
...The 44-year-old full-time mother has brought her three daughters — Lilly, Anna and Charlotte — along....
...Rival Eli Lilly has won approval for its own obesity drug, which could be more effective and currently has a lower list price....
...Results: Pharmaceutical companies Eli Lilly, Merck and Bristol Myers Squibb report results today, as do Southwest Airlines, Caterpillar and Honeywell....
...Eli Lilly is to apply for regulatory approval for an Alzheimer drug that a clinical study showed could slow the progress of cognitive decline in patients in the early stages....
...This would lift obesity from a $2.4bn category to a top-12 therapy area by global spending,” said Mark Purcell, analyst at Morgan Stanley....
...The results of the trial mark the second significant breakthrough in a year for a drug aiming to treat a disease with about 50mn sufferers worldwide....
...US drugmakers AbbVie and Eli Lilly in January became the first pharma companies to pull out of the voluntary scheme with the UK government in protest at the sharp rise in clawback payments....
...It is run by Mark Denham, head of European equities, and portfolio manager Obe Ejikeme....
...Pharmaceutical companies Eli Lilly, Merck and Bristol Myers Squibb also report....
...It marks the first time a big US pharmaceutical company has publicly announced plans to restrict exports of some medicines due to the war in Ukraine and comes as other drugmakers distance themselves from...
...US drugmakers AbbVie and Eli Lilly became the first big pharma groups to pull out of a pricing agreement with the UK after a sharp rise in the levy on branded medicines....
...Among the others reporting are McDonald's, Merck, Comcast, Southwest and Eli Lilly....
...There is talk of a character vanishing up their own umbilicus, which is a nice, self-aware joke but not wide of the mark....
...The Eli Lilly drug tackled both the virus and the body’s inflammatory reaction. The event marked the first time AI had discovered a drug, already in widespread use, that could be redeployed....
...Europe will receive up to 220,000 doses of monoclonal antibody treatment for Covid patients from US pharmaceutical company Eli Lilly under a deal announced on Tuesday....
International Edition